Nurse Practitioner, Family · Seymour, IN
NPI
1831550987
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
303 S Walnut St
Seymour, IN, 47274
Phone (812) 358-7705
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$36K
647 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Ngozi Igboko prescribed most often to Medicare patients was Ketoconazole, with 89 prescriptions and refills. In total Ngozi Igboko wrote 647 Medicare prescriptions that cost $36K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ketoconazole Generic | 89 | 97 | 46 | $1,290 |
| Clobetasol Propionate Generic | 76 | 81 | 43 | $1,300 |
| Triamcinolone Acetonide Generic | 67 | 70 | 40 | $1,716 |
| Desonide Generic | 37 | 38 | 24 | $577 |
| Finasteride Generic | 33 | 60 | Under 11 | $263 |
| Hydrocortisone Generic | 31 | 32 | 23 | $407 |
| Doxycycline Monohydrate Generic | 29 | 32 | Under 11 | $435 |
| Metronidazole Generic | 26 | 32 | 16 | $478 |
| Minoxidil Generic | 21 | 42 | Under 11 | $263 |
| Clindamycin Phos-Benzoyl Perox Clindamycin Phos/Benzoyl Perox | 19 | 19 | Under 11 | $877 |
| Fluocinonide Generic | 19 | 21 | 15 | $315 |
| Tacrolimus Generic | 16 | 17 | 11 | $907 |
| Ciclopirox Generic | 15 | 15 | Under 11 | $259 |
| Hydroxyzine Hcl Generic | 15 | 21 | Under 11 | $105 |
| Retin-A Tretinoin | 14 | 14 | Under 11 | $299 |
Brand drugs: 36 claims; generic drugs: 611 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ngozi Igboko were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.